CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer

By sjmartinez • March 30, 2025

Huynh JT, Li R, Shin DS. CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5):CRE25-050. doi: 10.6004/jnccn.2024.7225. PMID: 40154310.

Tags: Fellow, General Internal Medicine, Hematology/Oncology, Publications, Resident

Obesity and Long COVID: intersecting epidemics?

Gottlieb M, Yu H, Chen J, Spatz ES, Gentile NL, Geyer RE, Santangelo M, Malicki C, Gatling K, O'Laughlin KN, Stephens KA, Elmore JG, Wisk[...]

Central centrifugal cicatricial alopecia is associated with longer time to diagnosis among scarring alopecias

Issa T, Klomhaus AM, Kasakevich C, Pickford J, Goh C. Central centrifugal cicatricial alopecia is associated with longer time to diagnosis among scarring alopecias. JAAD[...]

Feasibility and Implementation of INTERVAL-GAP4: A Global Randomised Controlled Trial of Intense Hybrid-supervised/Self-managed Versus Self-directed Exercise for Metastatic Prostate Cancer

Kenfield SA, Hart NH, Courneya KS, Greenwood R, Chan JM, Sison J, Zhang L, Rudman S, Ung L, Schumann M, Van Blarigan EL, McKeown S,[...]